Industry updates with Dusko Ilic: January 2021

Written by Dusko ILIC
CAR-T Cell therapy FDA Industry developments Opinion

Read highlights from the latest installment of Dusko Ilic's industry news, which discuss the latest developments and news in regenerative medicine and stem cell research, and are published every month in Regenerative Medicine. Every month, Dusko comments on regenerative medicine industry news of note. Read the full update for January 2021 in Regenerative Medicine here >>> Find previous updates here>> What happened this month that you were expecting? Companies focused on immune cell-based cellular therapies for the treatment of cancer patients are running out of targets and they are actively seeking new ones. In October 2020, Boehringer Ingelheim (Germany) tapped...

To view this content, please register now for access

It's completely free